These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 31732528
1. Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus. Kulik L, Laskowski J, Renner B, Woolaver R, Zhang L, Lyubchenko T, You Z, Thurman JM, Holers VM. J Immunol; 2019 Dec 15; 203(12):3136-3147. PubMed ID: 31732528 [Abstract] [Full Text] [Related]
6. Novel function of complement C3d as an autologous helper T-cell target. Knopf PM, Rivera DS, Hai SH, McMurry J, Martin W, De Groot AS. Immunol Cell Biol; 2008 Jul 01; 86(3):221-5. PubMed ID: 18180801 [Abstract] [Full Text] [Related]
7. CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE. Boackle SA, Culhane KK, Brown JM, Haas M, Bao L, Quigg RJ, Holers VM. Autoimmunity; 2004 Mar 01; 37(2):111-23. PubMed ID: 15293881 [Abstract] [Full Text] [Related]
9. Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE). Asokan R, Banda NK, Szakonyi G, Chen XS, Holers VM. Mol Immunol; 2013 Jan 01; 53(1-2):99-110. PubMed ID: 22885687 [Abstract] [Full Text] [Related]
10. Role of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharide. Mitsuyoshi JK, Hu Y, Test ST. Infect Immun; 2005 Nov 01; 73(11):7311-6. PubMed ID: 16239528 [Abstract] [Full Text] [Related]
14. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. Takahashi K, Kozono Y, Waldschmidt TJ, Berthiaume D, Quigg RJ, Baron A, Holers VM. J Immunol; 1997 Aug 01; 159(3):1557-69. PubMed ID: 9233655 [Abstract] [Full Text] [Related]
15. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. Chen Z, Koralov SB, Kelsoe G. J Exp Med; 2000 Nov 06; 192(9):1339-52. PubMed ID: 11067882 [Abstract] [Full Text] [Related]
18. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists. Kulik L, Chen K, Huber BT, Holers VM. Mol Immunol; 2011 Mar 06; 48(6-7):883-94. PubMed ID: 21269698 [Abstract] [Full Text] [Related]
20. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Toapanta FR, Ross TM. Immunol Res; 2006 Jul 25; 36(1-3):197-210. PubMed ID: 17337780 [Abstract] [Full Text] [Related] Page: [Next] [New Search]